Chargement en cours...
Treating advanced kidney cancer—miles to go before we sleep
A randomized phase III trial comparing pazopanib with sunitinib in patients with advanced clear cell renal cell carcinoma showed that although progression-free survival and overall survival were similar, pazopanib was better tolerated. Recent advances in genomics and metabolomics have provided novel...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4174460/ https://ncbi.nlm.nih.gov/pubmed/24129349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.183 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|